Results 211 to 220 of about 181,462 (268)

Role of Sleep Disturbances and Diabetes‐Related Distress on Glycemic Control: A Path Analysis

Research in Nursing &Health, EarlyView.
ABSTRACT Despite advancements in diabetes management technology, many patients with type 2 diabetes (T2D) struggle to achieve optimal glycemic control. Sleep disorders such as obstructive sleep apnea (OSA) and insomnia are common in T2D and linked to poor glycemic control. Insomnia, particularly with short sleep duration, may worsen glycemic control by
Bomin Jeon, Faith S. Luyster, Eileen R. Chasens   +2 more
wiley   +1 more source

Obstructive Sleep Apnea and Postoperative Cognitive Decline in Non-Cardiac Surgery: A Prospective Cohort Study. [PDF]

Brain Behav
Kinjo S, In J, Lim E.
europepmc   +1 more source

Anterior palatoplasty as a treatment for mild and moderate obstructive sleep apnea: our experience [PDF]

Ionuţ Tănase, Shirley Tarabichi
openalex   +1 more source

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials

Obesity, EarlyView.
ABSTRACT Objective This study compared the efficacy of metabolic/bariatric surgery (MBS) and GLP‐1 receptor agonists (GLP‐1 RAs), including dual GLP‐1/GIP analogues, for weight and metabolic outcomes in adults with obesity. Methods A network meta‐analysis of randomized controlled trials compared MBS or GLP‐1 RAs versus lifestyle intervention in adults ...
Lucas Sabatella, Patricia M. Ortega, Víctor Valentí Azcárate, Fernando Rotellar Sastre, Adriana Uriz Pagola, Ahmed Ahmed, Sanjay Purkayastha, Carlota Tuero Ojanguren, Nuria Blanco Asensio, Manuel F. Landecho   +9 more
wiley   +1 more source

Lactate increases oxygen unloading of preconditioned blood from male elite breath-hold divers. [PDF]

Physiol Rep
Kjeld T, Hansen EG, Arendrup HC, Højberg J, Nedergaard A, Krag T, Vissing J.   +6 more
europepmc   +1 more source

Mobitz II atrioventricular block and CPAP response in a patient with severe obstructive sleep apnea, a case report [PDF]

Farkhondeh Nikkhah, Javad Setareh, Alireza Malekrah   +2 more
openalex   +1 more source

Weekly Subcutaneous VK2735, a GIP/GLP‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study

Obesity, EarlyView.
Four doses of VK2735 and a placebo group were included in the VENTURE study. Adults who were overweight or had obesity had significant weight loss when taking any dose of VK2735 for 13 weeks. More people lost at least 10% of their body weight as the dose increased.
Harold E. Bays, Phillip Toth, Naim Alkhouri, John Pullman, Bradley Freilich, Joel Neutel, Summer Ji, Scott Stubbe, Parke Hedges, Brian Lian   +9 more
wiley   +1 more source

Obstructive Sleep Apnea, Resting Heart Rate, and Glycemic Variability in Adults With Maturity-Onset Diabetes of the Young. [PDF]

Diabetes
Arosemena M, Chopra K, Salguero MV, Reyes D, Naylor RN, Wroblewski K, Tasali E, Philipson LH.   +7 more
europepmc   +1 more source

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

Obesity, EarlyView.
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden, Maria A. Oquendo, Robert F. Kushner, Dachuang Cao, Chrisanthi A. Karanikas, Afton Kechter, Madhumita A. Murphy   +6 more
wiley   +1 more source